| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
14,802 |
13,272 |
$3.92M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
16,462 |
15,283 |
$3.66M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,193 |
2,907 |
$2.07M |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
7,058 |
5,616 |
$1.80M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,462 |
3,171 |
$1.36M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
7,765 |
7,282 |
$1.24M |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,392 |
3,027 |
$1.12M |
| A0425 |
Ground mileage, per statute mile |
12,314 |
8,950 |
$1.10M |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
3,626 |
2,880 |
$975K |
| 80053 |
Comprehensive metabolic panel |
30,371 |
25,524 |
$895K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
3,412 |
3,300 |
$890K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
10,222 |
8,614 |
$822K |
| G0378 |
Hospital observation service, per hour |
1,261 |
1,077 |
$778K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
6,189 |
4,646 |
$703K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
10,272 |
8,148 |
$694K |
| 71045 |
Radiologic examination, chest; single view |
7,906 |
6,881 |
$585K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
9,091 |
7,626 |
$575K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
6,227 |
1,979 |
$510K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
9,137 |
8,205 |
$497K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
909 |
828 |
$478K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,768 |
2,719 |
$441K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
925 |
855 |
$423K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
31,436 |
25,924 |
$422K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,069 |
1,469 |
$329K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,306 |
1,297 |
$302K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
458 |
434 |
$291K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
560 |
524 |
$273K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
654 |
590 |
$262K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,778 |
4,815 |
$261K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,579 |
2,425 |
$246K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
372 |
357 |
$246K |
| 71046 |
Radiologic examination, chest; 2 views |
2,868 |
2,650 |
$211K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
2,629 |
865 |
$209K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,352 |
1,259 |
$201K |
| 36415 |
Collection of venous blood by venipuncture |
42,698 |
32,581 |
$193K |
| 80306 |
|
4,997 |
4,035 |
$166K |
| 84484 |
|
6,779 |
5,239 |
$159K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
1,280 |
1,075 |
$153K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
25,285 |
12,578 |
$153K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,461 |
2,986 |
$153K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
2,238 |
1,281 |
$140K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
293 |
279 |
$127K |
| J3490 |
Unclassified drugs |
15,026 |
7,092 |
$122K |
| 88313 |
|
2,331 |
2,215 |
$118K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,484 |
1,381 |
$110K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,726 |
1,637 |
$102K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
254 |
248 |
$93K |
| 73630 |
|
750 |
695 |
$85K |
| 83690 |
|
5,262 |
4,584 |
$85K |
| 73610 |
|
585 |
530 |
$83K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,245 |
643 |
$76K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,917 |
4,370 |
$71K |
| 73130 |
|
520 |
460 |
$70K |
| 86900 |
|
1,571 |
1,422 |
$69K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
213 |
151 |
$67K |
| 83605 |
|
4,931 |
4,019 |
$65K |
| 81001 |
|
7,202 |
6,403 |
$64K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
185 |
164 |
$61K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,756 |
2,236 |
$58K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
457 |
417 |
$57K |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,313 |
1,417 |
$56K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,659 |
2,511 |
$55K |
| 84703 |
|
3,220 |
3,015 |
$55K |
| 83880 |
|
1,922 |
1,732 |
$54K |
| A4649 |
Surgical supply; miscellaneous |
1,800 |
1,586 |
$51K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,144 |
2,088 |
$50K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
3,090 |
2,751 |
$46K |
| 73030 |
|
326 |
291 |
$44K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,129 |
1,598 |
$44K |
| 71250 |
|
122 |
100 |
$43K |
| 87040 |
|
1,987 |
1,186 |
$43K |
| 85379 |
|
1,378 |
1,292 |
$42K |
| 96376 |
|
2,131 |
1,564 |
$38K |
| 85027 |
|
3,444 |
2,922 |
$37K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
9,104 |
6,208 |
$37K |
| J2704 |
Injection, propofol, 10 mg |
5,019 |
3,562 |
$35K |
| 84702 |
|
1,686 |
1,441 |
$35K |
| 83735 |
|
2,692 |
2,183 |
$35K |
| 36591 |
|
430 |
233 |
$31K |
| 97113 |
|
298 |
112 |
$30K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
25 |
24 |
$29K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
206 |
77 |
$29K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
6,901 |
5,217 |
$29K |
| 96367 |
|
651 |
576 |
$29K |
| 73560 |
|
333 |
314 |
$28K |
| 59025 |
Fetal non-stress test |
327 |
229 |
$28K |
| 85610 |
|
3,819 |
3,312 |
$28K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
610 |
588 |
$27K |
| 87081 |
|
1,856 |
1,814 |
$25K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,393 |
3,185 |
$25K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
7,735 |
5,841 |
$23K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
122 |
113 |
$23K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
5,472 |
3,182 |
$23K |
| 82948 |
|
3,659 |
2,085 |
$22K |
| 73110 |
|
199 |
185 |
$22K |
| 86850 |
|
1,390 |
1,269 |
$21K |
| 76642 |
|
137 |
135 |
$21K |
| 81003 |
|
3,999 |
3,611 |
$21K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
141 |
136 |
$20K |
| 76536 |
|
119 |
98 |
$20K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,623 |
3,060 |
$19K |
| 88342 |
|
448 |
420 |
$18K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
283 |
275 |
$17K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
488 |
479 |
$17K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,471 |
4,666 |
$17K |
| 88312 |
|
205 |
203 |
$16K |
| 81025 |
|
1,230 |
1,182 |
$16K |
| 97162 |
|
212 |
207 |
$15K |
| 80143 |
|
370 |
346 |
$15K |
| 93971 |
|
122 |
118 |
$12K |
| 80061 |
Lipid panel |
698 |
685 |
$12K |
| 86901 |
|
1,576 |
1,422 |
$12K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
25 |
25 |
$11K |
| 87486 |
|
254 |
248 |
$10K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,598 |
1,349 |
$10K |
| 90715 |
|
374 |
369 |
$10K |
| 72100 |
|
101 |
101 |
$9K |
| 85730 |
|
989 |
915 |
$9K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
949 |
931 |
$9K |
| 80179 |
|
338 |
316 |
$9K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,143 |
1,799 |
$9K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,720 |
1,507 |
$8K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,804 |
1,741 |
$8K |
| 87581 |
|
254 |
248 |
$8K |
| 87186 |
|
440 |
403 |
$8K |
| 82805 |
|
140 |
117 |
$7K |
| 12001 |
|
37 |
36 |
$7K |
| 62323 |
|
33 |
27 |
$7K |
| 70486 |
|
14 |
13 |
$7K |
| 84439 |
|
458 |
439 |
$6K |
| 76770 |
|
31 |
30 |
$6K |
| 80299 |
|
250 |
109 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
137 |
133 |
$6K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,357 |
1,087 |
$6K |
| 94760 |
|
788 |
471 |
$6K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,871 |
937 |
$5K |
| 76641 |
|
25 |
24 |
$5K |
| J2060 |
Injection, lorazepam, 2 mg |
1,746 |
1,199 |
$5K |
| 80081 |
|
68 |
67 |
$5K |
| 85652 |
|
686 |
632 |
$5K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,959 |
1,378 |
$5K |
| 86141 |
|
249 |
231 |
$5K |
| 76830 |
Ultrasound, transvaginal |
27 |
26 |
$5K |
| 94799 |
|
28 |
28 |
$4K |
| 74022 |
|
65 |
60 |
$4K |
| 87070 |
|
312 |
264 |
$4K |
| 82550 |
|
302 |
254 |
$4K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
122 |
114 |
$4K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
122 |
114 |
$4K |
| 73562 |
|
28 |
12 |
$4K |
| 36600 |
|
116 |
101 |
$4K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,115 |
637 |
$3K |
| 51702 |
|
45 |
38 |
$3K |
| 74019 |
|
12 |
12 |
$3K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
33 |
30 |
$3K |
| 87807 |
|
166 |
164 |
$2K |
| 73090 |
|
14 |
12 |
$2K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
482 |
450 |
$2K |
| 96523 |
|
64 |
52 |
$2K |
| J3480 |
Injection, potassium chloride, per 2 meq |
286 |
152 |
$2K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
3,424 |
2,957 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
426 |
361 |
$2K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
60 |
24 |
$2K |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
176 |
171 |
$2K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
67 |
63 |
$2K |
| 74018 |
|
36 |
33 |
$2K |
| 73502 |
|
26 |
25 |
$1K |
| 83540 |
|
122 |
118 |
$1K |
| 77065 |
Tomosynthesis, mammo |
13 |
12 |
$1K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
208 |
173 |
$1K |
| 83550 |
|
70 |
68 |
$1K |
| 82728 |
|
42 |
42 |
$1K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
39 |
39 |
$1K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
28 |
12 |
$1K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
193 |
167 |
$905.92 |
| 87481 |
|
20 |
18 |
$787.24 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
29 |
25 |
$735.55 |
| J9303 |
Injection, panitumumab, 10 mg |
19 |
14 |
$679.52 |
| 86592 |
|
99 |
96 |
$651.53 |
| 87077 |
|
68 |
63 |
$647.88 |
| 88302 |
|
31 |
29 |
$638.75 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
42 |
42 |
$612.40 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
102 |
95 |
$525.76 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
15 |
15 |
$522.19 |
| 84550 |
|
39 |
28 |
$510.55 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
50 |
44 |
$506.60 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
135 |
88 |
$478.55 |
| 82565 |
|
98 |
91 |
$439.06 |
| 84100 |
|
38 |
25 |
$417.79 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
18 |
18 |
$393.58 |
| 86140 |
|
39 |
38 |
$345.28 |
| 97161 |
|
12 |
12 |
$335.26 |
| Q2038 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
28 |
28 |
$295.09 |
| 87660 |
|
16 |
16 |
$276.36 |
| 87510 |
|
16 |
16 |
$276.36 |
| 87480 |
|
16 |
16 |
$274.91 |
| 82947 |
|
43 |
43 |
$245.73 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
42 |
30 |
$243.64 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
233 |
181 |
$219.40 |
| A9270 |
Non-covered item or service |
47 |
31 |
$155.86 |
| 83615 |
|
12 |
12 |
$155.58 |
| J1815 |
Injection, insulin, per 5 units |
88 |
43 |
$152.05 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
89 |
42 |
$129.44 |
| C1758 |
Catheter, ureteral |
15 |
14 |
$103.03 |
| J1630 |
Injection, haloperidol, up to 5 mg |
18 |
12 |
$98.73 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
172 |
148 |
$84.16 |
| 85008 |
|
14 |
12 |
$71.83 |
| 87147 |
|
14 |
13 |
$68.88 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
16 |
13 |
$55.54 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
43 |
40 |
$38.96 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
12 |
12 |
$32.31 |
| S5001 |
Prescription drug, brand name |
18 |
12 |
$17.03 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13 |
12 |
$0.00 |